Hospital News and Research

RSS

Study on mice reveals that short term stress can prevent cancer

Researchers at the Stanford University School of Medicine have shown that, at least in laboratory mice, bouts of relatively short-term stress can boost the immune system and protect against one type of cancer. Furthermore, the beneficial effects of this occasional angst seem to last for weeks after the stressful situation has ended. The finding is surprising because chronic stress has the opposite effect -- taxing the immune system and increasing susceptibility to disease.

22 Sep 2009

MEDSEEK and Rex Healthcare sign multi-year agreement

MEDSEEK, the leading provider of enterprise-wide healthcare portal connectivity solutions, announced today that Rex Healthcare signed a multi-year agreement with MEDSEEK to design and implement a comprehensive eHealth ecoSystem, a virtual community in which patients, physicians and employees can collaborate to better manage health and more efficiently deliver healthcare, providing “the right information to the right person at the right time.”

22 Sep 2009

Electronic medical records cut costs and helps medical facilities to provide quality healthcare to patients

Electronic medical records have been a cornerstone of the successful health care formula prescribed by Dr. Richard Merkin, CEO for Heritage Provider Network. HPN and its 25 medical facilities in California and Healthcare Partners IPA in New York have been eliminating waste and cutting costs while providing quality healthcare to their patients for the past 30 years by focusing on the importance of integrating electronic medical records.

22 Sep 2009

Gene variant discovery could lead to future glaucoma treatments

An international team, led by researchers from the University of California, San Diego School of Medicine and the National Eye Institute, has discovered gene variants for glaucoma in a black population. The finding could lead to future treatments or a cure for this disease, which leads to blindness in two million Americans each year.

22 Sep 2009

IASIS Healthcare implements the Medicity Novo Grid solution to exchange health information electronically

Medicity, Inc. today announced that IASIS Healthcare went live with the Medicity Novo Grid solution in two (Florida and Utah) of its six regions. The solution enables IASIS to exchange health information electronically with providers connected on the Grid – whether the providers use an electronic health record (EHR) or operate a paper-based practice.

22 Sep 2009

Osteoporosis a growing concern in Asia

A new audit report issued by the International Osteoporosis Foundation (IOF) today shows that osteoporosis is a serious and growing problem throughout Asia.

22 Sep 2009

Intubation training could help improve emergency care

Virtually anyone has the skills to safely insert a laryngeal mask airway (LMA) to keep a patient's airway open during resuscitation, and medical expertise isn't required - perhaps just a familiarity with ER, House or Grey's Anatomy.

22 Sep 2009

U.S. hospital emergency departments not equipped to care for children

According to a recent IOM report, only 6 percent of U.S. hospital emergency departments are fully equipped to properly care for children. With high rates of novel H1N1 (swine) flu expected this winter, the time to address these deficiencies is immediate.

22 Sep 2009

Book on raising competent and independent children

Parents are tired and frustrated by current methods of discipline and punishment offered in books and media today. Parents understand that they are living in “The Discipline Trap,” believing that discipline is something we do to our children rather than something we teach them.

22 Sep 2009

Three-year results of SPIRIT III clinical trial reaffirms safety of PROMUS and TAXUS Express stents

Boston Scientific Corporation (NYSE: BSX) today welcomed three-year results from the SPIRIT III clinical trial, which continue to reaffirm the proven long-term safety of the Company's portfolio of drug-eluting stents, including the first-generation TAXUS((R)) Express(2)(TM) Paclitaxel-Eluting Coronary Stent System and the XIENCE V(TM) (PROMUS((R))) Everolimus-Eluting Coronary Stent System.

22 Sep 2009

Importance of residual thymopoiesis in aged adults

Doctor Manuel Leal is managing the Experimental Immune Virology Laboratory (in Virgen del Rocío University Hospital and Instituto de Biomedicina de Sevilla (IBIS), where clinic and basic science researchers work) where he leads a project to establish the functional nature of the thymus gland in adults. So far, it has been proven that this gland keeps on producing lymphocytes in the old age (Ferrando-Martínez et al. AGE, in press), which is a novelty because until very recently it was considered that this organ lost its immune capacity after the puberty.

22 Sep 2009

Researcher can anticipate immune response in Alzheimer's patients

A researcher who is working on a vaccine for Alzheimer's disease (AD) has demonstrated that it is possible to test and measure specific immune responses in mice carrying human genes and to anticipate the immune response in Alzheimer's patients. This continuing research at Ben-Gurion University of the Negev could one day lead to specific Alzheimer's vaccines that reduce plaque, neuronal damage and inflammation associated with the disease.

22 Sep 2009

New wireless Fractional Flow Reserve system to evaluate blood flow blockages in the arteries

St. Jude Medical, Inc. (NYSE: STJ) today announced the first use of the PressureWire™ Aeris technology, an interventional tool which measures Fractional Flow Reserve (FFR) to evaluate the severity of blood flow blockages in the arteries. This first-to-market technology helps interventional cardiologists better determine the ideal treatment option for their patients during coronary interventions, such as stent procedures.

22 Sep 2009

Study reveals effectiveness of drug-eluting stents in treating chronic total occlusions

A multicenter study in Asia found drug-eluting stents effective with a low rate of acute complications in patients with chronic total occlusions (CTOs) undergoing PCI. Results of the study will be presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).

22 Sep 2009

Coenzyme Q10 to slow down the effects of Parkinson's disease?

Rush University Medical Center is participating in a large-scale, multi-center clinical trial in the U.S. and Canada to determine whether a vitamin-like substance, in high doses, can slow the progression of Parkinson's disease, a neurodegenerative disorder that affects about one million people in the United States.

22 Sep 2009

Interim data from Micromet's T-cell engaging BiTE antibody study for treating solid tumors

Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today presented first interim data from a phase 1 dose-escalation clinical study for BiTE antibody MT110, the first T-cell engaging antibody for the treatment of solid tumors.

22 Sep 2009

HTA acquires GHS medical office building portfolio

Healthcare Trust of America, Inc., (the "REIT"), a self-managed non-traded real estate investment trust, announced the completed acquisition of a 16-building portfolio from Greenville Hospital System ("GHS") based in Greenville, South Carolina for approximately $162,820,000 on September 18, 2009.

22 Sep 2009

Older adults with vitamin D deficiency at a greater risk of heart disease and death

A new study by researchers at the University of Colorado Denver and Massachusetts General Hospital (MGH) shows vitamin D plays a vital role in reducing the risk of death associated with older age. The research, just published in the Journal of the American Geriatrics Society, evaluated the association between vitamin D levels in the blood and the death rates of those 65 and older. The study found that older adults with insufficient levels of vitamin D die from heart disease at greater rates that those with adequate levels of the vitamin.

22 Sep 2009

FDA approves Cordis Corporation's 2.25 mm CYPHER Stent

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the CYPHER® Sirolimus-eluting Coronary Stent, the world’s most studied drug-eluting stent that has been used to treat nearly 4 million people worldwide. The new 2.25 mm CYPHER® Stent is indicated for treatment of coronary blockages in small vessels, an often difficult-to-treat situation.

22 Sep 2009

Cook Medical launches the CE Marked Zilver PTX Drug-Eluting Peripheral Stent for treating PAD

In a breakthrough development that could dramatically reduce the number of leg amputations and painful bypass graft surgeries performed annually on European patients, a first-of-its kind drug-eluting stent for a widespread form of peripheral arterial disease (PAD) is now available to physicians throughout the European Union.

21 Sep 2009

Hospital News and Research

Study on mice reveals that short term stress can prevent cancer

MEDSEEK and Rex Healthcare sign multi-year agreement

Electronic medical records cut costs and helps medical facilities to provide quality healthcare to patients

Gene variant discovery could lead to future glaucoma treatments

IASIS Healthcare implements the Medicity Novo Grid solution to exchange health information electronically

Osteoporosis a growing concern in Asia

Intubation training could help improve emergency care

U.S. hospital emergency departments not equipped to care for children

Book on raising competent and independent children

Three-year results of SPIRIT III clinical trial reaffirms safety of PROMUS and TAXUS Express stents

Importance of residual thymopoiesis in aged adults

Researcher can anticipate immune response in Alzheimer's patients

New wireless Fractional Flow Reserve system to evaluate blood flow blockages in the arteries

Study reveals effectiveness of drug-eluting stents in treating chronic total occlusions

Coenzyme Q10 to slow down the effects of Parkinson's disease?

Interim data from Micromet's T-cell engaging BiTE antibody study for treating solid tumors

HTA acquires GHS medical office building portfolio

Older adults with vitamin D deficiency at a greater risk of heart disease and death

FDA approves Cordis Corporation's 2.25 mm CYPHER Stent

Cook Medical launches the CE Marked Zilver PTX Drug-Eluting Peripheral Stent for treating PAD

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News